Aidoc has received FDA Breakthrough Device status for its AI solution that flags multiple critical conditions in CT scans.
Key Details
- 1Aidoc's new AI product can detect a variety of urgent, life-threatening conditions from CT scans.
- 2The solution operates within a single workflow, streamlining triage for radiologists.
- 3This is believed to be the first FDA Breakthrough Device designation for an AI covering such a broad scope in one tool.
- 4The FDA Breakthrough Device Program is intended to speed market access for innovative medical technologies.
Why It Matters
Breakthrough Device status can accelerate regulatory review, paving the way for faster clinical adoption of comprehensive triage AI tools. This could improve patient outcomes by expediting the detection and management of critical conditions.
Source
Radiology Business
Related News
•AuntMinnie
AI Model Predicts Dosimetry for Lu-177 PSMA Therapy Using PET/CT
A machine learning PET/CT model shows promise for predicting radiation dose prior to Lu-177 PSMA therapy in prostate cancer patients.
•Radiology Business
DeepHealth's Prostate AI Gains FDA Clearance for MRI Workflows
DeepHealth, a RadNet subsidiary, received FDA clearance for its AI solution to assist prostate cancer detection and MRI workflow.
•AuntMinnie
Human-AI Collaboration Achieves 99.2% Sensitivity for PE Detection in CTPA
A large study confirms that combining radiologists with FDA-cleared AI significantly improves pulmonary embolism detection on CTPA.